All Articles

German CDMO Vetter wins a prestigious, client-voted award, underscoring its pivotal role and massive €2 billion investment in the world of injectable biologics.

An amended deal with Tasly positions AP Biosciences to license its innovative bispecific cancer therapy to global pharma giants, targeting a lucrative market.

A new SMART on FHIR app from AmericaWest lets hospital staff book medical rides in Epic, reducing a 31-minute task to less than one minute.

A new partnership aims to merge digital brain therapies with functional foods, targeting Japan and Southeast Asia's rapidly growing elderly populations.

A new drug not only reduces osteoarthritis pain significantly but may also be the first to modify the disease itself, a landmark study in The Lancet reveals.

South Korean AI chip leader Rebellions raises $400M, launching full-stack AI systems to redefine efficient inference and spearhead a global expansion.

Dubai's AIR, owner of Al Fakher, is going public via a SPAC merger. Can it navigate a tricky market and health debates to find growth on Wall Street?

Backed by a Turkish mining giant, Capella Minerals starts crucial soil sampling in Finland's prolific gold belt, seeking the next major discovery.

Aurinia Pharmaceuticals' deal for Kezar Life Sciences hinges on zetomipzomib, a promising but risky drug poised to tackle a rare autoimmune liver disease.

Constellis hires Joseph Zobro as Chief Legal Officer, signaling a strategic pivot towards agile procurement and integrating AI into its global security operations.

Chef Gabriela Cámara and architect Frida Escobedo debut a sanctuary of Mexican hospitality, offering a quiet, authentic counterpoint to the Vegas spectacle.

The NFL star's multi-year deal with the iconic American brand signals a major shift in athlete endorsements and a strategic play for cultural relevance.

With $8M in funding, Huskeys' new AI platform sits on top of existing firewalls, promising to stop blocking customers and start generating revenue.

A new software integration from Bond Sports and SUB-ZERO promises to eliminate operational friction, empowering staff and creating smarter, more efficient arenas.

As Precigen leaders prepare for a key investor chat, all eyes are on the explosive launch of PAPZIMEOS and the company's ambitious path to profitability.

Food-tech firm Beyond Oil is rolling out its oil-purifying tech in a top U.S. supermarket, promising healthier fried food and significant cost savings.

A shareholder proposal targeting GE's sales to Israel sparks a clash between human rights advocates and groups decrying it as a discriminatory BDS tactic.

BriteCap Financial brings on a seasoned CFO to scale its small business lending, signaling a strategic shift towards disciplined growth and market maturity.

The massive C$5.15 billion deal transforming Plains into a crude oil pure-play and Keyera into an NGL giant faces a delay amid a Competition Bureau review.

In an AI-obsessed world, strategic advisory firm Hakluyt bets on people, posting massive profit growth and adding tech titans to its elite board.